Gene therapy for hemophilia represents a groundbreaking advancement in the realm of hemophilia treatment, particularly for patients with hemophilia B.This innovative approach aims to correct the genetic mutations responsible for the condition, allowing the production of essential clotting factors that are often deficient in those affected.